Cochrane · systematic review · CD007894

Roselle for hypertension in adults

Pattanittum, P, Ngamjarus, C, Buttramee, F, et al. · Cochrane Database of Systematic Reviews · 2021 · Cochrane Library

Hypertension2 versionsAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
2
No studies
3
Included studies
NR
No studies 3 · 60%Ungraded 0 · 0%Very low 2 · 40%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Show all 2 versions

Roselle extract compared to placebo for hypertension in adults

Population: hypertension in adults with type 2 diabetes mellitus
5 questions
OutcomeEffectEvidenceStatus / GRADE
Change** in SBP at week 8 (mmHg)
Roselle extract vs placebo
no estimate extracted1 study · 52 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Change** in DBP at week 8 (mmHg)
Roselle extract vs placebo
no estimate extracted1 study · 52 participantsVery low
Downgraded: risk of bias, imprecision, indirectness
Withdrawals due to adverse effects
Roselle extract vs placebo
no estimate extractedNRNo studies
Change** in pulse pressure (mmHg)
Roselle extract vs placebo
no estimate extractedNRNo studies
Change** in heart rate (beats/min)
Roselle extract vs placebo
no estimate extractedNRNo studies